Fort Washington Investment Advisors Inc. OH lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 16.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 790,420 shares of the company's stock after selling 152,880 shares during the quarter. Fort Washington Investment Advisors Inc. OH owned 0.48% of Option Care Health worth $27,625,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of OPCH. Murphy & Mullick Capital Management Corp acquired a new position in Option Care Health during the 4th quarter worth about $26,000. Signaturefd LLC lifted its position in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after buying an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC lifted its position in Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after buying an additional 1,099 shares in the last quarter. Public Employees Retirement System of Ohio lifted its position in Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after buying an additional 332 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in Option Care Health during the 4th quarter worth about $47,000. Institutional investors own 98.05% of the company's stock.
Option Care Health Stock Up 0.7%
Shares of NASDAQ:OPCH traded up $0.22 during midday trading on Monday, reaching $31.82. 1,366,077 shares of the company were exchanged, compared to its average volume of 1,868,554. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock has a fifty day simple moving average of $32.20 and a two-hundred day simple moving average of $30.41. The firm has a market cap of $5.21 billion, a PE ratio of 26.74, a P/E/G ratio of 2.30 and a beta of 0.74.
Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same period in the previous year, the business earned $0.26 EPS. The company's revenue was up 16.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several research analysts have recently issued reports on the stock. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 30th. JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Finally, UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $35.50.
View Our Latest Research Report on OPCH
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.